®
  • Contact
  • Albumin
  • Products
    • Recombumin®
    • Sample page
  • Albumin Applications
    • COVID-19 Knowledge Hub
    • Cell therapy processing
    • Vaccine stabilization
    • Protein & Peptide formulation
    • Medical device coating
    • Veltis Technology
  • About
    • About Albumedix
    • Management
    • Partnering
      • R&D collaborations
      • Pipeline
    • Careers
    • CSR
    • FAQ
  • Media
    • Scientific Library
    • News & Events
    • Blog

News & Events

World leading manufacturer of recombinant human albumin

Albumedix Media News & Events Supporting Chalice Medical in their efforts to save lives

Supporting Chalice Medical in their efforts to save lives

30 Mar 2020

In a statement we released recently, Albumedix promised to work diligently to ensure minimal disruption to our supply chain, whilst keeping employee and customer safety as the number one priority. We’re happy to say we’re working very well towards this goal.

One of our valued medical device partners in the UK, Chalice Medical, is working around the clock to handle the huge surge in demand of their ECMO devices (oxygenators / life support machines). This surge has come as a result of the Covid-19 pandemic. In response, Albumedix are doing all we can to prioritize their shipments and any others related to the outbreak of the virus. 

We’re proud to play this small part in the battle against the novel coronavirus and will continue to support Chalice Medical as best we can in their incredible efforts to save lives.

 

Access the full Chalice Medical statement here

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with ~100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US

  • Albumin
  • Products
    • Recombumin®
    • Sample page
  • Albumin Applications
    • COVID-19 Knowledge Hub
    • Cell therapy processing
    • Vaccine stabilization
    • Protein & Peptide formulation
    • Medical device coating
    • Veltis Technology
  • About
    • About Albumedix
    • Management
    • Partnering
      • R&D collaborations
      • Pipeline
    • Careers
    • CSR
    • FAQ
  • Media
    • Scientific Library
    • News & Events
    • Blog

We use cookies on our website to improve the website and your experience.

Read more